BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1313402)

  • 1. Non-A non-B hepatitis and hepatitis C virus.
    Katz L
    Iowa Med; 1992 Feb; 82(2):71-3. PubMed ID: 1313402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C virus].
    Roggendorf M; Schlipköter U
    Beitr Infusionsther; 1991; 28():13-21. PubMed ID: 1725610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
    Abb J
    Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
    Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
    Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of posttransfusional non-A, non-B hepatitis by a screening test for hepatitis C virus antibody of donor bloods.
    Ito S; Takaoka T; Kajimoto Y; Muguruma N; Fukuda T; Okabe T; Horikita M; Hibino S; Hayashi H; Honda H
    Tokushima J Exp Med; 1991 Jun; 38(1-2):19-23. PubMed ID: 1719660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-borne non-A, non-B hepatitis: hepatitis C.
    Genesca J; Esteban JI; Alter HJ
    Semin Liver Dis; 1991 May; 11(2):147-64. PubMed ID: 1653459
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders].
    Zenz W; Hofmann H; Muntean W
    Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody prevalence for hepatitis C and other parenterally transmissible viral diseases in i. v. drug dependent patients].
    Neuwald C; Pont J; Tomasits J; Bauer K
    Acta Med Austriaca; 1992; 19(2):47-8. PubMed ID: 1324551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction of the proportion of anti-HCV-positive donations].
    Quiles FJ; Sanz A; Cabanillas A; Sáenz P; Sánchez GM; Díaz F
    Sangre (Barc); 1992 Apr; 37(2):153-4. PubMed ID: 1320294
    [No Abstract]   [Full Text] [Related]  

  • 19. [All blood donors should be tested to stop the transmission of hepatitis C virus].
    Högman C; Iwarson S; Lindholm A; Nordenfelt E; Weiland O
    Lakartidningen; 1990 Aug; 87(34):2555-6. PubMed ID: 2120521
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to hepatitis C virus and surrogate marker testing of blood donors to prevent non-A, non-B hepatitis.
    Kakaiya R; Stephans J; Carnahan G; Ahmed P; Miller WV
    Transfusion; 1991 Oct; 31(8):780-1. PubMed ID: 1656555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.